Elevance Health, Inc. logo

Elevance Health, Inc. (ELV)

Market Open
5 Dec, 14:33
NYSE NYSE
$
332. 27
+0.53
+0.16%
$
75.23B Market Cap
18.21 P/E Ratio
6.52% Div Yield
23,903 Volume
33.06 Eps
$ 331.74
Previous Close
Day Range
330.74 333.84
Year Range
273.71 458.75
Want to track ELV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?

Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?

Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 8 months ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks | 8 months ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks | 8 months ago
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?

Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?

With a strengthening commercial business, ELV is seeing steady membership growth.

Zacks | 8 months ago
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio

Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio

Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.

Seekingalpha | 8 months ago
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?

Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?

Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks | 8 months ago
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now

Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now

Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective.

Seekingalpha | 9 months ago
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)

Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)

Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.

Seekingalpha | 9 months ago
Elevance Health Bolsters Employer Insurance Business

Elevance Health Bolsters Employer Insurance Business

Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an Elevance spokeswoman said.

Forbes | 9 months ago
5 Stocks With Above-Market Yields Just Raised Payments Further

5 Stocks With Above-Market Yields Just Raised Payments Further

With the stock market going through its first earnings season of 2025, companies are making important announcements. This includes the approval of share buyback programs, as well as dividend increases.

Marketbeat | 10 months ago
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are redefining how healthcare providers manage data, deliver care, and enhance patient outcomes.

Marketbeat | 10 months ago
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums

Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums

ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership partially offset the positives.

Zacks | 10 months ago
Loading...
Load More